Sputnik V authorised by Mexio authorities for Covid-19 emergency use

Elias Hubbard
February 4, 2021

An interim analysis from a Phase III trial of the Sputnik V vaccine has shown it is effective against symptomatic COVID-19.

Medical journal The Lancet this week published results of Sputnik V saying the vaccine has an efficacy of 91.6 per cent and is safe to use.

The shot faced Western criticism previous year when it was approved in Russian Federation before large-scale clinical trials.

Once the use of Sputnik V was authorized, the Russians have the "commitment to send 400,000 doses to Mexico in very few days".

"People there really need the vaccine", he said.

On Wednesday, the banner headline of the pro-Kremlin Izvestia daily's front page celebrated the "successful launch" of the jab.

Last spring, Alexander Gintsburg, the director of the state-run Gamaleya research centre that developed Sputnik V, boasted of having personally injected himself with an experimental version of the jab.

Efficacy of the vaccine was calculated on the basis of the proportion of participants with PCR-confirmed COVID-19.

The Russian Direct Investment Fund (RDIF), which markets the Sputnik V vaccine overseas, said at the weekend it did not supply the breakaway regions of eastern Ukraine.

The regulating agency approved the Pfizer vaccine in December and AstraZeneca's in January.

Initial trial finds Russia vaccine 91.6% efficient, EU does not rule out a deal
Russia's Sputnik V Covid-19 vaccine 91.6% effective | The New Times | Rwanda

More than a million people in Russian Federation have received Sputnik V, which is marketed overseas by the RDIF and has been approved for emergency use in Algeria, Argentina, Bolivia, Mexico and Serbia.

Dr. Reddy's has been working with the Russian Direct Investment Fund (RDIF) to hold small clinical trials of Sputnik V in India.

Peskov said Russian Federation was working to further boost production of the vaccine in foreign nations.

"The number of countries that register this vaccine at home is increasing every day", he said. "If not us, then no one would supply it there".

Asked about Sputnik V, French President Emmanuel Macron said on Tuesday that a few weeks ago, he had sent a scientific mission to Russian Federation and the exchanges were positive. They said it was made and released in a hurry without any information.

Faced with hurdles with a vaccine roll-out in her country, German Chancellor Angela Merkel said on Tuesday that the Russian jab could be used in the European Union if it receives official approval. So far, nothing has gone wrong with the national vaccination campaign. The trial was conducted across 25 hospitals and polyclinics in Moscow, Russia. The vaccine is therefore called Sputnik V.

16 countries have already registered the vaccine for emergency use, with half of them intending to produce the vaccine.

By Wednesday, Russia had reported 3.9 million coronavirus infections - the fourth-highest caseload in the world.

Peskov dismissed those concerns.

The European Commission said Monday (1 February) the shortfall in deliveries from Anglo-Swedish firm AstraZeneca had forced it to recalibrate its early coronavirus vaccination strategy.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER